MOLCURE has been selected for Microsoft for Startups, a start-up program supported by Microsoft. Microsoft for […]
An interview with our CEO Ryu Ogawa was published in the web magazine EL BORDE. ウェブマガジン EL BORDEに、CEO 小川のインタビュ […]
Our CCO Shoji Ihara will speak at the “Business matching for companies specializing in medical and health care […]
We will be exhibiting at PharmaLab EXPO 2020 / Interphex Week at Makuhari Messe in Chiba, Japan from November […]
Our CTO Yutaro Kyono will speak at the “Message from a Venture Companies Online Corporate Matching in Shinkawa […]
Our CEO Ryu Ogawa will speak about Drug Development at the CPhI Japan Webinar on Nov 13, 14:15 JST. 11月13日開催の中 […]
We are excited to announce that MOLCURE will be exhibiting at Bio Japan 2020! MOLCUREはBioJapan2020に出展します。 Link […]
We ranked 1st in Artificial Intelligence at the Shenzhen Advanced Technology Pitch Contest Japan Qualifying To […]
MOLCURE participated in the 1st Shenzhen Advanced Technology Pitch Contest Japan Qualifying Tournament. 第1回 深セ […]
Our CEO Dr. Ryu Ogawa and CSO Dr. Satoshi Tamaki were interviewed by Pharma Boardroom about MOLCURE’s impact i […]